SlideShare une entreprise Scribd logo
1  sur  24
Télécharger pour lire hors ligne
Quality System Expectations

          Disposables (Single-Use
          Materials) use in the Manufacture
          of Drugs and Biologics


    Bill Holden
    Global Quality Leader
    W. L. Gore & Associates, Inc.
    Gore PharmBIO products
Agenda
 Single-Use Technologies Movement
 cGMP CFR 820 Applicable Practices
 Supplier Qualifications
 Material Qualifications
 Minimal Quality System Standards
Single-Use in Pharma & Biotech
 Single-Use technologies supply materials
 to the biomanufacturing process that
 replace the need for stainless steel and
 traditional manufacturing processes which
 require extensive validation and process
 development.
What is the Movement?
Increased availability of Single-Use
  materials are replacing traditional stainless
  steel processes.
  – Use in Single batch or limited campaigns
  – Reduced process validations
  – Validations allow for re-usable elements
Advantages
    Decreased Cycle times (Batch to Batch)
    Decrease Overall Captial Investment
    Decreased Labor
    Decreased New Product Introductions time
    Increased Flexibility
    Increased Potential Capacity
    Decreased In Process Waste
Disadvantages
    New Extractables/ Leachables must be determined
    for product
    Increased cost of consummables
    Increased need for Vendor Audits
    Qualified Supply Sources are limited
    Increased potential for scrap of unused
    components
    More Solid Waste
The Path to Single-Use Process
                  Systems

Traditional     Single-use
stainless       BioProcess
steel           Container Systems

Large capital    Less capital
SIP              No SIP
CIP              No CIP
  validation       validation
Ameican Pharmaceutical Review ( See web links References and Resources)
Supplier Qualification (Expectations)

  Limited Validated Suppliers
  Expectations of Minimal Quality Standards
  Applicable cGMP standards

                         ISO                         cGMP
                                        21 CFR 820



                        Extractable      CARS/
                                         PARS
                                                     Audit

                         Supply                      Training
                                          Robust
                         Control          Quality
                         Traceability
                                          System
Applicable cGMP 21 CFR 820
 Applicability 820.1 (a)
 – Current good manufacturing practice (CGMP)
   requirements are set forth in this quality system
   regulation. The requirements in this part govern the
   methods used in, and the facilities and controls used
   for, the design, manufacture, packaging, labeling,
   storage, installation, and servicing of all finished
   devices intended for human use.
 – If a manufacturer engages in only some operations
   subject to the requirements in this part, and not in
   others, that manufacturer need only comply with those
   requirements applicable to the operations in which it
   is engaged.
Suggested Applicable Requirements
for tubing Molded Manifolds
 Subpart B--Quality System Requirements
  § 820.20 - Management responsibility.
  § 820.22 - Quality audit.
  § 820.25 - Personnel.
 Subpart C--Design Controls
  § 820.30 - Design controls.
 Subpart D--Document Controls
  § 820.40 - Document controls.
 Subpart E--Purchasing Controls
  § 820.50 - Purchasing controls.
 Subpart F--Identification and Traceability
  § 820.60 - Identification.
  § 820.65 - Traceability.
 Subpart G--Production and Process Controls
  § 820.70 - Production and process controls.
  § 820.72 - Inspection, measuring, and test equipment.
  § 820.75 - Process validation.
 Subpart H--Acceptance Activities
  § 820.80 - Receiving, in-process, and finished device acceptance.
  § 820.86 - Acceptance status.
Suggested Applicable Requirements
for tubing Molded Manifolds
 Subpart I--Nonconforming Product
  § 820.90 - Nonconforming product.
 Subpart J--Corrective and Preventive Action
  § 820.100 - Corrective and preventive action.
 Subpart K--Labeling and Packaging Control
  § 820.120 - Device labeling.
  § 820.130 - Device packaging.
 Subpart L--Handling, Storage, Distribution, and Installation
  § 820.140 - Handling.
  § 820.150 - Storage.
  § 820.160 - Distribution.
  § 820.170 - Installation.
 Subpart M--Records
  § 820.180 - General requirements.
  § 820.181 - Device master record.
  § 820.184 - Device history record.
  § 820.186 - Quality system record.
  § 820.198 - Complaint files.
 Subpart N--Servicing
  § 820.200 - Servicing.
 Subpart O--Statistical Techniques
  § 820.250 - Statistical techniques.
Basic Requirements (Manufacturing)

 ISO 9001:2008 3rd Party certification
 Demonstrable Quality System
  – Responsible Quality Unit/Team
  – Trained, responsible production team
    members
  – Appropriate Document Management System
      Controlled Documents
      Demonstrable Procedures, Work Instructions, etc.
Basic Requirements (Manufacturing)

 Viable Preventative and Corrective Action
 Systems
 Controlled and verified suppliers
  – Approved supplier list
  – Verified materials (TSE/BSE Policy)
 Identification and Traceability Systems
  – Manual or Electronic
Basic Requirements (Manufacturing)

 Appropriate Production Controls
  –   In Process Assurance of Intermediate Assembly
  –   In Process Traceability
  –   In Process Acceptance Standards
  –   Equipment Validations/ Calibrations/ Preventative
      Maintenance
 Appropriate isolation and identification of non-
 conforming product
  – Segregation/ labeling, and disposition
Basic Requirements (Manufacturing)

 Organized Handling Operations
  – Controlled labels and identification of parts
    and components
  – Assurance of packaging integrity of parts and
    components
  – Assurance of cleanliness of parts and
    components
  – Viable location traceability (manual or
    electronic)
Basic Requirements (Manufacturing)

 Records
  – DMF/DHF- Batch History Record
      Includes the Bill of Materials (BOM, Drawing,
      additional customer specifications)
      Assures traceability of part manufacture and raw
      components
      Assures any linkage from customer complaint can
      be made.
Basic Requirements (Manufacturing)

 Internal Audits
  – Yearly Internal Evaluations
 Facilities
  – Clean and Organized
  – Bioburden/ Particulate readings
  – Appropriate environmental and disposal
    controls for the parts manufactured.
  – Pest control program and maintenance
Basic Requirements (Materials)
 Sterilization method /validations              (GAMMA/ STEAM, etc. )


 Chemical Compatibility
 Physical Properties
 Extractables Test Data
 Biocompatibility (USP VI Test Data)
 Applicable Materials Testing
  – Application specific testing
       Endotoxin
       Bioburden
       FFU (Fitness for Use) specific testing
Methods of Evaluation
 Desktop Audit
 Supplier Visit/Audit
 Data Review
 Supplier Performance Data
  – Delivery
  – Corrective Actions
  – Collaborations
Desktop Survey
 Frequent Topics:
Additional Resources
 References
  – Froimson, Joshua. American Pharmaceutical
    Review. 2009. 12, 2 20-27.
  – Sinclair, Andrew, Monge, Miram.
    International BioPharm. 2008. 21, 12 27-29.
  – Strahlendorf, Kirsten A. Kevin Harper.
    American Pharmaceutical Review. 2009. 12, 4
    28-37.
Additional Resources
 Web Resources
  –   http://www.futurepharmaus.com/?mc=disposable&page=mt-viewarticle
  –   http://www.pharmamanufacturing.com/articles/2007/164.html
  –   http://www.pharmpro.com/ShowPR.aspx?PUBCODE=021&ACCT=0000100&ISSUE=0604
      &RELTYPE=PR&ORIGRELTYPE=ATO&PRODCODE=0000&PRODLETT=A&Commo
      nCount=0
  –   http://biopharminternational.findpharma.com/biopharm/Disposables/Final-Word-Disposable-
      Systems-Meet-Todays-Manufact/ArticleStandard/Article/detail/146352
  –   http://www.bioplanassociates.com/publications/articles/Bp0607_DisposablesAsDisruptive_J
      un07.pdf
  –   http://www.pharmamanufacturing.com/articles/2004/27.html?page=full
 Additional Meetings
  –   http://www2.ispe.org/annualmeeting2009/education/402.cfm
  –   http://www.pharmpro.com/singleuse/
  –   http://www.advantagemedia.com/ims/scripts/RegisterEventLink.asp?ID=79
  –   http://www.ispe.org/cs/2009_strasbourg_conference/disposables_and_containment_technolo
      gy
  –   http://biopharminternational.findpharma.com/biopharm/Disposables+Advisor/User-
      Viewpoints-on-Disposables-
      Implementation/ArticleStandard/Article/detail/601411?contextCategoryId=35801
Additional Resources
 http://biopharminternational.findpharma.com/biopharm/s
 ervlet/ContentRatingServlet#rating_anchor
 http://biopharminternational.findpharma.com/biopharm//a
 rticle/articleDetail.jsp?ts=081709022143&id=608683
 http://biopharminternational.findpharma.com/biopharm/a
 rticle/articleDetail.jsp?id=608683&pageID=1&sk=&date
 =
 http://www.in-pharmatechnologist.com/Processing-
 QC/GE-Healthcare-and-Novavax-collaborate-on-
 pandemic-flu-solution

Contenu connexe

Tendances

Clean In Place - Cycle Development
Clean In Place - Cycle DevelopmentClean In Place - Cycle Development
Clean In Place - Cycle Development
Ranjeet Kumar
 
Pharmaceuticals standard piping agru
Pharmaceuticals standard piping agruPharmaceuticals standard piping agru
Pharmaceuticals standard piping agru
mandalika3
 
Clean In Place Technlogies BioPharma Facilities
Clean In Place Technlogies BioPharma FacilitiesClean In Place Technlogies BioPharma Facilities
Clean In Place Technlogies BioPharma Facilities
Ranjeet Kumar
 
Biomanufacturing flexibility
Biomanufacturing flexibilityBiomanufacturing flexibility
Biomanufacturing flexibility
GBX Summits
 

Tendances (20)

E+H Life Sciences Magazine May 2015
E+H Life Sciences Magazine May 2015E+H Life Sciences Magazine May 2015
E+H Life Sciences Magazine May 2015
 
Flexible Aseptic Manufacturing
Flexible Aseptic ManufacturingFlexible Aseptic Manufacturing
Flexible Aseptic Manufacturing
 
E+H - Global Offering for LIfe Sciences
E+H - Global Offering for LIfe SciencesE+H - Global Offering for LIfe Sciences
E+H - Global Offering for LIfe Sciences
 
Whey, Water and CIP Detergent?
Whey, Water and CIP Detergent?Whey, Water and CIP Detergent?
Whey, Water and CIP Detergent?
 
Flexible Aseptic Manufacturing
Flexible Aseptic ManufacturingFlexible Aseptic Manufacturing
Flexible Aseptic Manufacturing
 
CIP article from food engineering magazine Jan 2015
CIP article from food engineering magazine Jan 2015CIP article from food engineering magazine Jan 2015
CIP article from food engineering magazine Jan 2015
 
Clean In Place - Cycle Development
Clean In Place - Cycle DevelopmentClean In Place - Cycle Development
Clean In Place - Cycle Development
 
BioPharmEquip 04_22.pptx
BioPharmEquip 04_22.pptxBioPharmEquip 04_22.pptx
BioPharmEquip 04_22.pptx
 
Clean-in-place: how to ensure food safety while maintaining equipment effecti...
Clean-in-place: how to ensure food safety while maintaining equipment effecti...Clean-in-place: how to ensure food safety while maintaining equipment effecti...
Clean-in-place: how to ensure food safety while maintaining equipment effecti...
 
Isolator-Barrier Integrated Robotics
Isolator-Barrier Integrated RoboticsIsolator-Barrier Integrated Robotics
Isolator-Barrier Integrated Robotics
 
Pharmaceuticals standard piping agru
Pharmaceuticals standard piping agruPharmaceuticals standard piping agru
Pharmaceuticals standard piping agru
 
Water system validation.
Water system validation.Water system validation.
Water system validation.
 
Purified Water System in Pharmaceuticals
Purified Water System in PharmaceuticalsPurified Water System in Pharmaceuticals
Purified Water System in Pharmaceuticals
 
mcd_SOAR A
mcd_SOAR Amcd_SOAR A
mcd_SOAR A
 
Tracking Single-Use & Scale-Up Best Practices
Tracking Single-Use & Scale-Up Best PracticesTracking Single-Use & Scale-Up Best Practices
Tracking Single-Use & Scale-Up Best Practices
 
An Overview of Biologics Manufacturing Processes and Things to Consider from ...
An Overview of Biologics Manufacturing Processes and Things to Consider from ...An Overview of Biologics Manufacturing Processes and Things to Consider from ...
An Overview of Biologics Manufacturing Processes and Things to Consider from ...
 
Clean In Place Technlogies BioPharma Facilities
Clean In Place Technlogies BioPharma FacilitiesClean In Place Technlogies BioPharma Facilities
Clean In Place Technlogies BioPharma Facilities
 
E+H - inline quality measurement
E+H -  inline quality measurementE+H -  inline quality measurement
E+H - inline quality measurement
 
CEC Filtration
CEC FiltrationCEC Filtration
CEC Filtration
 
Biomanufacturing flexibility
Biomanufacturing flexibilityBiomanufacturing flexibility
Biomanufacturing flexibility
 

Similaire à Quality System Expectations : Single-Use Materials

Elements of a Quality System for Medical Devices
Elements of a Quality System for Medical DevicesElements of a Quality System for Medical Devices
Elements of a Quality System for Medical Devices
Raul Soto
 
Validation Theory And Application 3
Validation   Theory And Application 3Validation   Theory And Application 3
Validation Theory And Application 3
antoi alvarez
 
2016 David R. Todd resume
2016 David R. Todd resume2016 David R. Todd resume
2016 David R. Todd resume
David Todd
 

Similaire à Quality System Expectations : Single-Use Materials (20)

Facility & Equipment Quality System Outline
Facility & Equipment Quality System OutlineFacility & Equipment Quality System Outline
Facility & Equipment Quality System Outline
 
Quality manual
Quality manualQuality manual
Quality manual
 
ICHQ7 & Q11 (4 of 7)
ICHQ7 & Q11 (4 of 7)ICHQ7 & Q11 (4 of 7)
ICHQ7 & Q11 (4 of 7)
 
ICH Q7 & Q11
ICH Q7 & Q11ICH Q7 & Q11
ICH Q7 & Q11
 
Computerized system validation (CSV) as a requirement for good manufacturing ...
Computerized system validation (CSV) as a requirement for good manufacturing ...Computerized system validation (CSV) as a requirement for good manufacturing ...
Computerized system validation (CSV) as a requirement for good manufacturing ...
 
Cleanroom Qualification
Cleanroom QualificationCleanroom Qualification
Cleanroom Qualification
 
Effective Medical Device Validation Introduction Web 2
Effective Medical Device Validation Introduction   Web 2Effective Medical Device Validation Introduction   Web 2
Effective Medical Device Validation Introduction Web 2
 
validation ppt.pptx
 validation ppt.pptx validation ppt.pptx
validation ppt.pptx
 
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...
 
Validation ksd
Validation ksdValidation ksd
Validation ksd
 
Validation
ValidationValidation
Validation
 
GMP quality assurance
GMP quality assuranceGMP quality assurance
GMP quality assurance
 
Incorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation PlanIncorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation Plan
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & Validation
 
Elements of a Quality System for Medical Devices
Elements of a Quality System for Medical DevicesElements of a Quality System for Medical Devices
Elements of a Quality System for Medical Devices
 
Excipient Auditing
Excipient AuditingExcipient Auditing
Excipient Auditing
 
P rocess validation 1
P rocess validation 1P rocess validation 1
P rocess validation 1
 
Validation Theory And Application 3
Validation   Theory And Application 3Validation   Theory And Application 3
Validation Theory And Application 3
 
SAP in Pharmaceutical Industry
SAP in Pharmaceutical IndustrySAP in Pharmaceutical Industry
SAP in Pharmaceutical Industry
 
2016 David R. Todd resume
2016 David R. Todd resume2016 David R. Todd resume
2016 David R. Todd resume
 

Dernier

+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
?#DUbAI#??##{{(☎️+971_581248768%)**%*]'#abortion pills for sale in dubai@
 

Dernier (20)

FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu SubbuApidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source Milvus
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdf
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 

Quality System Expectations : Single-Use Materials

  • 1. Quality System Expectations Disposables (Single-Use Materials) use in the Manufacture of Drugs and Biologics Bill Holden Global Quality Leader W. L. Gore & Associates, Inc. Gore PharmBIO products
  • 2. Agenda Single-Use Technologies Movement cGMP CFR 820 Applicable Practices Supplier Qualifications Material Qualifications Minimal Quality System Standards
  • 3. Single-Use in Pharma & Biotech Single-Use technologies supply materials to the biomanufacturing process that replace the need for stainless steel and traditional manufacturing processes which require extensive validation and process development.
  • 4. What is the Movement? Increased availability of Single-Use materials are replacing traditional stainless steel processes. – Use in Single batch or limited campaigns – Reduced process validations – Validations allow for re-usable elements
  • 5. Advantages Decreased Cycle times (Batch to Batch) Decrease Overall Captial Investment Decreased Labor Decreased New Product Introductions time Increased Flexibility Increased Potential Capacity Decreased In Process Waste
  • 6. Disadvantages New Extractables/ Leachables must be determined for product Increased cost of consummables Increased need for Vendor Audits Qualified Supply Sources are limited Increased potential for scrap of unused components More Solid Waste
  • 7. The Path to Single-Use Process Systems Traditional Single-use stainless BioProcess steel Container Systems Large capital Less capital SIP No SIP CIP No CIP validation validation
  • 8. Ameican Pharmaceutical Review ( See web links References and Resources)
  • 9. Supplier Qualification (Expectations) Limited Validated Suppliers Expectations of Minimal Quality Standards Applicable cGMP standards ISO cGMP 21 CFR 820 Extractable CARS/ PARS Audit Supply Training Robust Control Quality Traceability System
  • 10. Applicable cGMP 21 CFR 820 Applicability 820.1 (a) – Current good manufacturing practice (CGMP) requirements are set forth in this quality system regulation. The requirements in this part govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of all finished devices intended for human use. – If a manufacturer engages in only some operations subject to the requirements in this part, and not in others, that manufacturer need only comply with those requirements applicable to the operations in which it is engaged.
  • 11. Suggested Applicable Requirements for tubing Molded Manifolds Subpart B--Quality System Requirements § 820.20 - Management responsibility. § 820.22 - Quality audit. § 820.25 - Personnel. Subpart C--Design Controls § 820.30 - Design controls. Subpart D--Document Controls § 820.40 - Document controls. Subpart E--Purchasing Controls § 820.50 - Purchasing controls. Subpart F--Identification and Traceability § 820.60 - Identification. § 820.65 - Traceability. Subpart G--Production and Process Controls § 820.70 - Production and process controls. § 820.72 - Inspection, measuring, and test equipment. § 820.75 - Process validation. Subpart H--Acceptance Activities § 820.80 - Receiving, in-process, and finished device acceptance. § 820.86 - Acceptance status.
  • 12. Suggested Applicable Requirements for tubing Molded Manifolds Subpart I--Nonconforming Product § 820.90 - Nonconforming product. Subpart J--Corrective and Preventive Action § 820.100 - Corrective and preventive action. Subpart K--Labeling and Packaging Control § 820.120 - Device labeling. § 820.130 - Device packaging. Subpart L--Handling, Storage, Distribution, and Installation § 820.140 - Handling. § 820.150 - Storage. § 820.160 - Distribution. § 820.170 - Installation. Subpart M--Records § 820.180 - General requirements. § 820.181 - Device master record. § 820.184 - Device history record. § 820.186 - Quality system record. § 820.198 - Complaint files. Subpart N--Servicing § 820.200 - Servicing. Subpart O--Statistical Techniques § 820.250 - Statistical techniques.
  • 13. Basic Requirements (Manufacturing) ISO 9001:2008 3rd Party certification Demonstrable Quality System – Responsible Quality Unit/Team – Trained, responsible production team members – Appropriate Document Management System Controlled Documents Demonstrable Procedures, Work Instructions, etc.
  • 14. Basic Requirements (Manufacturing) Viable Preventative and Corrective Action Systems Controlled and verified suppliers – Approved supplier list – Verified materials (TSE/BSE Policy) Identification and Traceability Systems – Manual or Electronic
  • 15. Basic Requirements (Manufacturing) Appropriate Production Controls – In Process Assurance of Intermediate Assembly – In Process Traceability – In Process Acceptance Standards – Equipment Validations/ Calibrations/ Preventative Maintenance Appropriate isolation and identification of non- conforming product – Segregation/ labeling, and disposition
  • 16. Basic Requirements (Manufacturing) Organized Handling Operations – Controlled labels and identification of parts and components – Assurance of packaging integrity of parts and components – Assurance of cleanliness of parts and components – Viable location traceability (manual or electronic)
  • 17. Basic Requirements (Manufacturing) Records – DMF/DHF- Batch History Record Includes the Bill of Materials (BOM, Drawing, additional customer specifications) Assures traceability of part manufacture and raw components Assures any linkage from customer complaint can be made.
  • 18. Basic Requirements (Manufacturing) Internal Audits – Yearly Internal Evaluations Facilities – Clean and Organized – Bioburden/ Particulate readings – Appropriate environmental and disposal controls for the parts manufactured. – Pest control program and maintenance
  • 19. Basic Requirements (Materials) Sterilization method /validations (GAMMA/ STEAM, etc. ) Chemical Compatibility Physical Properties Extractables Test Data Biocompatibility (USP VI Test Data) Applicable Materials Testing – Application specific testing Endotoxin Bioburden FFU (Fitness for Use) specific testing
  • 20. Methods of Evaluation Desktop Audit Supplier Visit/Audit Data Review Supplier Performance Data – Delivery – Corrective Actions – Collaborations
  • 22. Additional Resources References – Froimson, Joshua. American Pharmaceutical Review. 2009. 12, 2 20-27. – Sinclair, Andrew, Monge, Miram. International BioPharm. 2008. 21, 12 27-29. – Strahlendorf, Kirsten A. Kevin Harper. American Pharmaceutical Review. 2009. 12, 4 28-37.
  • 23. Additional Resources Web Resources – http://www.futurepharmaus.com/?mc=disposable&page=mt-viewarticle – http://www.pharmamanufacturing.com/articles/2007/164.html – http://www.pharmpro.com/ShowPR.aspx?PUBCODE=021&ACCT=0000100&ISSUE=0604 &RELTYPE=PR&ORIGRELTYPE=ATO&PRODCODE=0000&PRODLETT=A&Commo nCount=0 – http://biopharminternational.findpharma.com/biopharm/Disposables/Final-Word-Disposable- Systems-Meet-Todays-Manufact/ArticleStandard/Article/detail/146352 – http://www.bioplanassociates.com/publications/articles/Bp0607_DisposablesAsDisruptive_J un07.pdf – http://www.pharmamanufacturing.com/articles/2004/27.html?page=full Additional Meetings – http://www2.ispe.org/annualmeeting2009/education/402.cfm – http://www.pharmpro.com/singleuse/ – http://www.advantagemedia.com/ims/scripts/RegisterEventLink.asp?ID=79 – http://www.ispe.org/cs/2009_strasbourg_conference/disposables_and_containment_technolo gy – http://biopharminternational.findpharma.com/biopharm/Disposables+Advisor/User- Viewpoints-on-Disposables- Implementation/ArticleStandard/Article/detail/601411?contextCategoryId=35801
  • 24. Additional Resources http://biopharminternational.findpharma.com/biopharm/s ervlet/ContentRatingServlet#rating_anchor http://biopharminternational.findpharma.com/biopharm//a rticle/articleDetail.jsp?ts=081709022143&id=608683 http://biopharminternational.findpharma.com/biopharm/a rticle/articleDetail.jsp?id=608683&pageID=1&sk=&date = http://www.in-pharmatechnologist.com/Processing- QC/GE-Healthcare-and-Novavax-collaborate-on- pandemic-flu-solution